Targeting mosquito larvae and not adults could worsen dengue epidemics, study says

NewsGuard 100/100 Score

Targeting only mosquito larvae and not adult insects in insecticide-based dengue control programs could increase mosquito resistance and decrease human immunity to the disease, particularly in urban areas, according to a study published online in the Lancet on Tuesday, Agence France-Presse reports.

Approximately 2.5 billion people are at risk of dengue worldwide, and incidence has risen dramatically over the past few decades because of increased urbanization and rising temperatures attributed to global warming, the news service writes. There is no cure, treatment or vaccine for the disease, and the only way to fight it is to eliminate the mosquitoes that carry it, especially the Aedes aegypti (Hood, 5/2).

Using mathematical and computer modeling of dengue transmission, researchers examined the cost effectiveness of 43 different insecticide-based interventions and found that all the methods caused insecticide resistance, which when coupled with a loss of human immunity, "will increase the magnitude of future dengue epidemics," the researchers wrote (Luz et al., 5/3). The vector control method "prevailing in most countries - attempting to destroy breeding areas - is misguided, according to the study," AFP reports.

"The main conclusion is that when you compare all the proposals for controlling dengue, the most cost effective is killing adult mosquitoes," Eduardo Massad, a professor at the School of Medicine at the University of Sao Paulo who was not involved in the study, said, according to AFP. He added, "The most applied strategy is to search and destroy breeding places. This has not worked well - we need a new strategy, one that doesn't exist yet" (5/2).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    WHO recommends R21/Matrix-M vaccine for malaria prevention in children